Ficus Technology Holdings Limited (8107.HK) Entering into a Cooperation Agreement with the subsidiary of China Supply and Trade Group to Synergise Channel and Supply Chain Resources

EQS Newswire / 29/08/2024 / 23:30 UTC+8 Ficus Technology Holdings Limited(Incorporated in the Cayman Islands with limited liability) (Stock Code: 8107)     Entering into a Cooperation Agreement with the subsidiary of China Supply and Trade Group To Synergise Channel and Supply Chain Resources   (Hong Kong - 29 August…

Kazakhstan’s Kaspi.kz (KSPI) Eyes Acquisition of Uzbekistan’s Humo Payment System: A Strategic Move Amidst Regional Expansion

EQS Newswire / 29/08/2024 / 15:38 UTC+4 Kaspi.kz (KSPI), the fintech giant from Kazakhstan, has announced its intention to participate in the privatization of Humo, one of Uzbekistan’s leading payment systems. This move is seen as a significant step in the company’s broader strategy to expand its footprint across Central…

Trio Industrial Electronics Group’s revenue for the six months ended 30 June 2024 amounted to HK$389.2 million; Continue to Develop ‘Greater Asia Sustainable Energy Business Circle’

EQS Newswire / 28/08/2024 / 22:57 UTC+8   Trio Industrial Electronics Group's revenue for the six months ended 30 June 2024 amounted to HK$389.2 million; Continue to Develop ‘Greater Asia Sustainable Energy Business Circle’   [Hong Kong – 28 August 2024] Trio Industrial Electronics Group Limited (“Trio Group” or the…

Ficus Technology Holdings Limited (8107.HK) Entering into a Cooperation Agreement with Shenbei Community Service Centre Co-nurturing Target Customers in Local Communities

EQS Newswire / 28/08/2024 / 01:09 UTC+8   Ficus Technology Holdings Limited   (Incorporated in the Cayman Islands with limited liability) (Stock Code: 8107)   Entering into a Cooperation Agreement with Shenbei Community Service Centre Co-nurturing Target Customers in Local Communities   (Hong Kong - 27 August 2024) Innovative supply…

Sihuan Pharmaceutical (00460.HK): Subsidiary Huisheng Biopharmaceutical Reshapes Diabetes Treatment Landscape With Two Home-Grown Insulin Products

EQS Newswire / 21/08/2024 / 10:07 UTC+8 1. With Two Home-Grown Insulin Products Approved for Marketing, It Leads the Development of The Domestic Insulin MarketOn August 6th, Sihuan Pharmaceutical (00460.HK) announced that Insulin Degludec and Insulin Aspart Injection (trade name: Huiyoujia), developed by its subsidiary Huisheng Biopharmaceutical, was approved for…